全文获取类型
收费全文 | 26519篇 |
免费 | 1297篇 |
国内免费 | 256篇 |
专业分类
耳鼻咽喉 | 213篇 |
儿科学 | 513篇 |
妇产科学 | 620篇 |
基础医学 | 2788篇 |
口腔科学 | 523篇 |
临床医学 | 2285篇 |
内科学 | 7773篇 |
皮肤病学 | 565篇 |
神经病学 | 2338篇 |
特种医学 | 928篇 |
外科学 | 4311篇 |
综合类 | 62篇 |
一般理论 | 5篇 |
预防医学 | 953篇 |
眼科学 | 346篇 |
药学 | 1375篇 |
中国医学 | 43篇 |
肿瘤学 | 2431篇 |
出版年
2024年 | 27篇 |
2023年 | 224篇 |
2022年 | 464篇 |
2021年 | 776篇 |
2020年 | 488篇 |
2019年 | 643篇 |
2018年 | 768篇 |
2017年 | 591篇 |
2016年 | 725篇 |
2015年 | 787篇 |
2014年 | 1002篇 |
2013年 | 1375篇 |
2012年 | 2126篇 |
2011年 | 2083篇 |
2010年 | 1223篇 |
2009年 | 1097篇 |
2008年 | 1911篇 |
2007年 | 1804篇 |
2006年 | 1656篇 |
2005年 | 1662篇 |
2004年 | 1523篇 |
2003年 | 1352篇 |
2002年 | 1251篇 |
2001年 | 167篇 |
2000年 | 120篇 |
1999年 | 177篇 |
1998年 | 220篇 |
1997年 | 202篇 |
1996年 | 161篇 |
1995年 | 184篇 |
1994年 | 155篇 |
1993年 | 142篇 |
1992年 | 95篇 |
1991年 | 78篇 |
1990年 | 96篇 |
1989年 | 59篇 |
1988年 | 56篇 |
1987年 | 40篇 |
1986年 | 50篇 |
1985年 | 52篇 |
1984年 | 56篇 |
1983年 | 41篇 |
1982年 | 53篇 |
1981年 | 33篇 |
1980年 | 44篇 |
1979年 | 25篇 |
1978年 | 15篇 |
1977年 | 17篇 |
1975年 | 20篇 |
1974年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. 总被引:2,自引:0,他引:2
Giuseppe Pelosi Aldo Scarpa Michela Manzotti Giulia Veronesi Lorenzo Spaggiari Filippo Fraggetta Oscar Nappi Elvira Benini Felice Pasini Davide Antonello Antonio Iannucci Patrick Maisonneuve Giuseppe Viale 《Modern pathology》2004,17(5):538-546
We investigated 27 pleomorphic carcinomas of the lung for exon 1 K-ras gene mutations using polymerase chain reaction-single-strand conformation polymophism analysis and direct sequencing. All pleomorphic carcinomas were biphasic, that is, composed of an adeno-, squamous- or large-cell-carcinomatous component associated with a spindle- and/or giant-cell component. Of 27 cases, six (22%) showed K-ras codon 12 mutations, which is a figure higher than that previously reported on in pure sarcoma-like pleomorphic carcinomas. Five tumors displayed the same mutation in both the epithelial and the sarcomatoid components, whereas in one tumor the mutation was restricted to the epithelial component. All mutations occurred in smokers, and were transversions, including GGT (glycine) to TGT (cysteine) change in two cases, to GCT (alanine) in two and to GTT (valine) in two. No significant relationships were found between the occurrence and type of mutations and patients' survival or any other clinicopathological variable, suggesting that K-ras mutations are early events in the development of these tumors. Our results indicate that most, though not all, biphasic pleomorphic carcinomas of the lung are monoclonal in origin, and that cigarette smoking may have a causative role in the development of K-ras alterations in these tumors, as all mutations are transversions. 相似文献
112.
Bertini M Ferrara M De Gennaro L Curcio G Fratello F Romei V Pauri F Rossini PM 《Journal of sleep research》2004,13(1):31-36
Transcranial magnetic stimulation (TMS) is a recently established technique in the neurosciences that allows the non-invasive assessment, among other parameters, of the excitability of motor cortex. Up to now, its application to sleep research has been very scarce and because of technical problems it provided contrasting results. In fact delivering one single suprathreshold magnetic stimulus easily awakes subjects, or lightens their sleep. For this reason, in the present study we assessed motor thresholds (MTs) upon rapid eye movement (REM) and non-rapid eye movement (NREM) sleep awakenings, both in the first and in the last part of the night. Taking into account that a full re-establishment of wake regional brain activity patterns upon awakening from sleep needs up to 20-30 min, it is possible to make inferences about the neurophysiological characteristics of the different sleep stages by analyzing the variables of interest immediately after provoked awakenings. Ten female volunteers slept in the lab for four consecutive nights. During the first night the MTs were collected, following a standardized procedure: 5 min before lights off, upon stage 2 awakening (second NREM period), upon REM sleep awakening (second REM period), upon the final morning awakening (always from stage 2). Results showed that MTs increased linearly from presleep wakefulness to REM sleep awakenings, and from the latter to stage 2 awakenings. There was also a time-of-night effect on MTs upon awakening from stage 2, indicating that MTs decreased from the first to the second part of the night. The increase in corticospinal excitability across the night, which parallels the fulfillment of sleep need, is consistent with the linear decrease of auditory arousal thresholds during the night. The maximal reduction of corticospinal excitability during early NREM sleep can be related to the hyperpolarization of thalamocortical neurons, and is in line with the decreased metabolic activity of motor cortices during this sleep stage. On the contrary, the increase of MTs upon REM sleep awakenings should reflect peripheral factors. We conclude that our findings legitimate the introduction of the TMS technique as a new proper tool in sleep research. 相似文献
113.
Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development 总被引:6,自引:0,他引:6
Uda M Ottolenghi C Crisponi L Garcia JE Deiana M Kimber W Forabosco A Cao A Schlessinger D Pilia G 《Human molecular genetics》2004,13(11):1171-1181
FOXL2 mutations cause gonadal dysgenesis or premature ovarian failure (POF) in women, as well as eyelid/forehead dysmorphology in both sexes (the 'blepharophimosis-ptosis-epicanthus inversus syndrome', BPES). Here we report that mice lacking Foxl2 recapitulate relevant features of human BPES: males and females are small and show distinctive craniofacial morphology with upper eyelids absent. Furthermore, in mice as in humans, sterility is confined to females. Features of Foxl2 null animals point toward a new mechanism of POF, with all major somatic cell lineages failing to develop around growing oocytes from the time of primordial follicle formation. Foxl2 disruption thus provides a model for histogenesis and reproductive competence of the ovary. 相似文献
114.
115.
Patrizia Canale Francesco Squadrito Domenica Altavilla Mariapatrizia Ioculano Basilia Zingarelli Giuseppe M. Campo Giuseppe Urna Aurora Sardella Giovanni Squadrito Achille P. Capuli 《Inflammation research》1994,42(3-4):128-134
The aim of this study was to evaluate: (1) the accumulation of leukocytes in the ileum and the lung during splanchnic artery occlusion (SAO) shock; (2) the role of platelet-activating factor (PAF) and tumor necrosis factor (TNF-) in this phenomenon. Untreated anesthetized rats subjected to total occlusion of the celiac, superior and inferior mesenteric arteries for 45 min, followed by reperfusion, uniformly died within 90 min after reperfusion. The mean survival time was 93±7 min. The neutrophilic infiltrate was quantitated in the ileum and in the lung using a myeloperoxidase (MPO) assay. MPO activity in the ileum and in the lung averaged 0.05±0.03 and 0.4±0.02 U×10–3/g protein in animals killed before occlusion. MPO activity did not change in rats killed immediately before reperfusion and was significantly elevated (0.11±0.02 and 1.7±0.6 U×10–3/g protein in the ileum and the lung, respectively) in those killed 80 min after the beginning of the reperfusion. The histological examination confirmed the accumulation of leukocytes in the mucosa of the ileum and the lung over the 80 min. SAO shocked rats exhibited leukopenia and increased serum levels of TNF-. In order to evaluate the role of PAF and TNF- in SAO shock, a powerful PAF receptor antagonist, TCV-309 (5 g/kg i.v.), was injected 5 min after reperfusion. TCV-309 increased survival time, lowered serum TNF-, reduced MPO activity in both the ileum and the lung and ameliorated leukopenia induced by SAO shock. In addition, the drug significantly reduced ileal necrosis and pulmonary morphological alterations induced by shock. These results suggest an important role for PAF in the adhesion of leukocytes in SAO shock. 相似文献
116.
Giuseppe Giuffrè Rosario Alberto Caruso Gaetano Barresi G. Tuccari 《Virchows Archiv : an international journal of pathology》1998,432(3):261-266
To assess the prognostic significance of silver-stained nucleolar organizer region (AgNOR) proteins, a standardized AgNOR
analysis was performed on 78 patients affected by early (EGC, n=24) or advanced (AGC, n=54) gastric carcinomas. The histopathological diagnosis, grading and staging were done according to WHO and UICC recommendations;
the mean follow-up time was 56.9 months. Visualization and quantification of AgNORs were made in formalin-fixed, paraffin-embedded
sections as specified in the guidelines of the Committee on AgNOR Quantification (1995). Statistical analysis was performed
on the mean AgNOR area values (NORA). Highly significant differences (P<0.001) were found in NORA values between EGC and AGC, between low- and high-grade gastric carcinomas and between patients
dead from gastric cancer and living patients. In addition, significant P values were found on comparison of NORA values relating to pT status, pN status and stage. Comparison of Kaplan-Meier survival
curves revealed that patients affected by gastric carcinomas with higher NORA values (>5.213 μm2) had a worse prognosis. Finally, using Cox multiple regression analysis, the AgNOR quantity emerged as a useful independent
prognostic variable to predict the final outcome of patients affected by EGC or AGC.
Received: 26 September 1997 / Accepted: 26 January 1998 相似文献
117.
118.
Montalto G Giannitrapani L Soresi M Virruso L Martino DD Gambino R Carroccio A Cervello M 《Inflammation》2001,25(2):101-108
E-selectin, an adhesion molecule of the selectin family, is involved in leukocyte adhesion to the endothelium and in the cellular immunological reactions. Expression of this molecule, in fact, is physiologically absent, but it becomes evident on sinusoidal lining cells during inflammatory liver disease. The aim of this study was to evaluate the behavior of E-selectin in chronic hepatitis C (CH-C) patients with persistently normal transaminase in comparison to patients with CH-C and elevated transaminase, and its changes during alpha-interferon therapy. Immunohistochemical localization of E-selectin was also performed on liver tissue specimens of both groups. Fifty-eight subjects were divided into 3 groups: group A included 18 patients with CH-C and persistently normal transaminase; group B 20 patients with CH-C and persistently elevated transaminase levels and group C included 20 healthy subjects, representing the control group. The first two groups were treated with r-IFN at a dose of 6 MU 3 times a week for 3 months and followed-up with 3 MU 3 times a week for another 3 months. Serum baseline values of E-selectin in groups A and B were significantly higher than those in group C (P < 0.04), but there was no difference between groups A and B. Furthermore, there was a trend toward higher E-selectin values as histological severity increased (r = 0.69; P < 0.0001). Post-treatment E-selectin serum values showed a moderate decrease in both groups, but only among responder patients; while E-selectin levels were unchanged in non responders. Immunohistochemical localization showed no staining for E-selectin in normal liver specimens, while there was a quite similar staining for E-selectin in the two groups of patients. In conclusion, this study shows that serum E-selectin levels in patients with CH-C and persistently normal transaminase are higher than in controls and they are associated with severity of liver disease. Liver of these patients express E-selectin molecules, suggesting an activation of the immune system almost identical to that of patients with CH-C and elevated transaminase. In both groups only responder patients showed a moderate decrease below baseline serum values. 相似文献
119.
Michikawa Y Laderman K Richter K Attardi G 《Somatic Cell and Molecular Genetics》1999,25(5-6):333-342
Previous work had shown a large accumulation (up to 50% of mtDNA) of a noninherited T414G transversion at a critical control site for mtDNA replication in skin fibroblasts from the majority of human subjects above 65 years old, and its absence in younger individuals. In the present studies, long-term in vitro culture of several fibroblasts populations carrying the heteroplasmic T414G mutation revealed an outgrowth of the mutant cells by wild-type cells. This observation supported the previous conclusion that the mutation accumulation is an in vivo phenomenon, while, at the same time, indicating intrinsic physiological differences between mutant and wild-type cells. Furthermore, subcloning experiments revealed a striking mosaic distribution of the mutation in the original fibroblasts populations, as shown by its presence, in heteroplasmic or homoplasmic form, in a fraction (18–32%) of the fibroblasts, and its absence in the others. In other investigations, transfer of mitochondria from mutation-carrying fibroblasts into mtDNA-less 143B.TK–0 206 cells revealed the persistence of the mosaic distribution of the mutation, however, with a near-complete shift to homoplasmy. The generality of the latter phenomenon would exclude a founder effect by one or few mitochondria in the transformation experiments, and would rather point to the important role of the nuclear background in the in vitro behavior of the T414G mutation. The stability of the homoplasmic mutation in 0 cell transformants provides a powerful tool for analyzing its biochemical effects. 相似文献
120.
Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases. 总被引:2,自引:0,他引:2
Emanuela Maserati Fiorenza Aprili Fabrizio Vinante Franco Locatelli Giovanni Amendola Adriana Zatterale Giuseppe Milone Antonella Minelli Franca Bernardi Francesco Lo Curto Francesco Pasquali 《Genes, chromosomes & cancer》2002,33(1):93-97
The trisomy 8 found in malignancies may derive from a constitutional trisomy 8 mosaicism (CT8M), and in these cases the trisomy itself may be regarded as the first mutation in a multistep carcinogenetic process. To assess the frequency of CT8M in hematological dysplastic and neoplastic disorders with trisomy 8, an informative sample of 14 patients was collected. The data ascertained included chromosome analyses of fibroblast cultures and of PHA-stimulated blood cultures in patients with normal blood differential count, as well as possible CT8M clinical signs. One patient showed trisomy 8 in all cell types analyzed and undoubtedly has a CT8M; a second patient consistently showed trisomy 8 in PHA-stimulated blood cultures when no immature myeloid cells were present in blood and should be considered as having CT8M; a third patient, with Philadelphia-positive chronic myelocytic leukemia, was more difficult to interpret, but the possibility that she had CT8M is likely. A few clinical signs of CT8M were also present in these three patients. Our data indicate that the frequency of CT8M in hematological dysplastic and neoplastic disorders with trisomy 8 is approximately 15-20%. 相似文献